T. Andrew Crockett
2017
In 2017, T. Andrew Crockett earned a total compensation of $605.3K as Chief Executive Officer at Carbylan Therapeutics.
Compensation breakdown
| Bonus | $213,750 |
|---|---|
| Salary | $390,076 |
| Other | $1,500 |
| Total | $605,326 |
Crockett received $390.1K in salary, accounting for 64% of the total pay in 2017.
Crockett also received $213.8K in bonus and $1.5K in other compensation.
Rankings
In 2017, T. Andrew Crockett's compensation ranked 11,158th out of 14,666 executives tracked by ExecPay. In other words, Crockett earned more than 23.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,158 out of 14,666 | 24th |
Division Manufacturing | 4,365 out of 5,772 | 24th |
Major group Chemicals And Allied Products | 1,582 out of 2,075 | 24th |
Industry group Drugs | 1,302 out of 1,731 | 25th |
Industry Pharmaceutical Preparations | 1,016 out of 1,333 | 24th |
Source: SEC filing on August 23, 2019.
Crockett's colleagues
We found one more compensation record of an executive who worked with T. Andrew Crockett at Carbylan Therapeutics in 2017.
2017
Benjamin Palleiko
Carbylan Therapeutics